The project entails agreeing upon interventions of known or estimable efficacy that are appropriate for high-, moderate- and low-resource scenarios. The focus is not on individual drugs, although these must be included, but on the means by which these reached and are used by people who are likely to benefit from them (which include educational programmes for healthcare providers and the public).

The project also entails agreeing the bases of effect and cost measurement and then running the analytical WHO-CHOICE model, entering the regional epidemiological data we supplied to GBD2010, and the disability weights estimated in that study.

Collaborator:

• D Chisholm, World Health Organization, Geneva, Switzerland